158 related articles for article (PubMed ID: 8311852)
1. Role of platelet-derived growth factor in glomerular disease.
Johnson RJ; Floege J; Couser WG; Alpers CE
J Am Soc Nephrol; 1993 Aug; 4(2):119-28. PubMed ID: 8311852
[TBL] [Abstract][Full Text] [Related]
2. PDGF signal transduction inhibition ameliorates experimental mesangial proliferative glomerulonephritis.
Gilbert RE; Kelly DJ; McKay T; Chadban S; Hill PA; Cooper ME; Atkins RC; Nikolic-Paterson DJ
Kidney Int; 2001 Apr; 59(4):1324-32. PubMed ID: 11260393
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of mesangial cell proliferation and matrix expansion in glomerulonephritis in the rat by antibody to platelet-derived growth factor.
Johnson RJ; Raines EW; Floege J; Yoshimura A; Pritzl P; Alpers C; Ross R
J Exp Med; 1992 May; 175(5):1413-6. PubMed ID: 1569407
[TBL] [Abstract][Full Text] [Related]
4. Heparin suppresses mesangial cell proliferation and matrix expansion in experimental mesangioproliferative glomerulonephritis.
Floege J; Eng E; Young BA; Couser WG; Johnson RJ
Kidney Int; 1993 Feb; 43(2):369-80. PubMed ID: 8441232
[TBL] [Abstract][Full Text] [Related]
5. Platelet-derived growth factor (PDGF) and PDGF receptor are induced in mesangial proliferative nephritis in the rat.
Iida H; Seifert R; Alpers CE; Gronwald RG; Phillips PE; Pritzl P; Gordon K; Gown AM; Ross R; Bowen-Pope DF
Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6560-4. PubMed ID: 1713682
[TBL] [Abstract][Full Text] [Related]
6. Trapidil inhibits human mesangial cell proliferation: effect on PDGF beta-receptor binding and expression.
Gesualdo L; Di Paolo S; Ranieri E; Schena FP
Kidney Int; 1994 Oct; 46(4):1002-9. PubMed ID: 7861694
[TBL] [Abstract][Full Text] [Related]
7. Counteractive effects of HGF on PDGF-induced mesangial cell proliferation in a rat model of glomerulonephritis.
Bessho K; Mizuno S; Matsumoto K; Nakamura T
Am J Physiol Renal Physiol; 2003 Jun; 284(6):F1171-80. PubMed ID: 12595276
[TBL] [Abstract][Full Text] [Related]
8. Caveolae in mesangial cells and caveolin expression in mesangial proliferative glomerulonephritis.
Tamai O; Oka N; Kikuchi T; Koda Y; Soejima M; Wada Y; Fujisawa M; Tamaki K; Kawachi H; Shimizu F; Kimura H; Imaizumi T; Okuda S
Kidney Int; 2001 Feb; 59(2):471-80. PubMed ID: 11168929
[TBL] [Abstract][Full Text] [Related]
9. Effect of the platelet-derived growth factor antagonist trapidil on mesangial cell proliferation in rats.
Futamura A; Izumino K; Nakagawa Y; Takata M; Inoue H; Iida H
Nephron; 1999; 81(4):428-33. PubMed ID: 10095179
[TBL] [Abstract][Full Text] [Related]
10. Temporal expression of autocrine growth factors corresponds to morphological features of mesangial proliferation in Habu snake venom-induced glomerulonephritis.
Barnes JL; Abboud HE
Am J Pathol; 1993 Nov; 143(5):1366-76. PubMed ID: 8238253
[TBL] [Abstract][Full Text] [Related]
11. Multiple roles for platelet-derived growth factor in renal disease.
Floege J; Johnson RJ
Miner Electrolyte Metab; 1995; 21(4-5):271-82. PubMed ID: 7565476
[TBL] [Abstract][Full Text] [Related]
12. [The role of platelet-derived growth factor in progression of nephropathy].
Spustová V; Oksa A; Dzúrik R
Vnitr Lek; 1996 Dec; 42(12):842-8. PubMed ID: 9072884
[TBL] [Abstract][Full Text] [Related]
13. A fully human monoclonal antibody (CR002) identifies PDGF-D as a novel mediator of mesangioproliferative glomerulonephritis.
Ostendorf T; van Roeyen CR; Peterson JD; Kunter U; Eitner F; Hamad AJ; Chan G; Jia XC; Macaluso J; Gazit-Bornstein G; Keyt BA; Lichenstein HS; LaRochelle WJ; Floege J
J Am Soc Nephrol; 2003 Sep; 14(9):2237-47. PubMed ID: 12937299
[TBL] [Abstract][Full Text] [Related]
14. Expression of a novel PDGF isoform, PDGF-C, in normal and diseased rat kidney.
Eitner F; Ostendorf T; Van Roeyen C; Kitahara M; Li X; Aase K; Gröne HJ; Eriksson U; Floege J
J Am Soc Nephrol; 2002 Apr; 13(4):910-917. PubMed ID: 11912250
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic compound (TNP-470) inhibits mesangial cell proliferation in vitro and in vivo.
Haraguchi M; Okamura M; Konishi M; Konishi Y; Negoro N; Inoue T; Kanayama Y; Yoshikawa J
Kidney Int; 1997 Jun; 51(6):1838-46. PubMed ID: 9186873
[TBL] [Abstract][Full Text] [Related]
16. SPARC is expressed by mesangial cells in experimental mesangial proliferative nephritis and inhibits platelet-derived-growth-factor-medicated mesangial cell proliferation in vitro.
Pichler RH; Bassuk JA; Hugo C; Reed MJ; Eng E; Gordon KL; Pippin J; Alpers CE; Couser WG; Sage EH; Johnson RJ
Am J Pathol; 1996 Apr; 148(4):1153-67. PubMed ID: 8644857
[TBL] [Abstract][Full Text] [Related]
17. Platelet-derived growth factor and proliferative glomerulonephritis.
Gesualdo L; Ranieri E; Pannarale G; Di Paolo S; Schena FP
Kidney Int Suppl; 1993 Jan; 39():S86-9. PubMed ID: 8468932
[No Abstract] [Full Text] [Related]
18. Dissociation of mesangial cell migration and proliferation in experimental glomerulonephritis.
Haseley LA; Hugo C; Reidy MA; Johnson RJ
Kidney Int; 1999 Sep; 56(3):964-72. PubMed ID: 10469364
[TBL] [Abstract][Full Text] [Related]
19. Mitogenic effect of platelet-derived growth factor in human glomerular mesangial cells: modulation and/or suppression by inflammatory cytokines.
Floege J; Topley N; Hoppe J; Barrett TB; Resch K
Clin Exp Immunol; 1991 Nov; 86(2):334-41. PubMed ID: 1657466
[TBL] [Abstract][Full Text] [Related]
20. Participation of glomerular endothelial cells in the capillary repair of glomerulonephritis.
Iruela-Arispe L; Gordon K; Hugo C; Duijvestijn AM; Claffey KP; Reilly M; Couser WG; Alpers CE; Johnson RJ
Am J Pathol; 1995 Dec; 147(6):1715-27. PubMed ID: 7495296
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
